
|Articles|November 21, 2019
Challenging Microbial Sanitization of a Liquid Chromatography System
To ensure that no contaminating or hazardous residual components remain after protein purification during biologic development, additional sanitization steps may be required for the instrumentation utilized during these processes.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
Samsung Biologics Bolsters US Manufacturing Network with GSK Facility Buy
2
Novel Delivery Approaches of Biopharmaceuticals 2025
3
GSK and CAMP4 Partner to Advance RNA-Targeting Therapeutics
4
EMA Director Highlights Agency Achievements in 2025
5